SCHEMBL1742890

SCHEMBL1742890

O=C(c1ccccc1)N(Oc1ccc2[nH]ccc2c1)S(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
RAB9A P51151 1/20 0.43
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
MAOA P21397 1/20 0.39
KAT6A Q92794 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
BCL2L1 Q07817 1/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1744608 0.91 SLC6A2 (0.46) MAPTNPC1SLC6A2SLC6A4SLC6A3
SCHEMBL1745461 0.84 ESR1 (0.45) MAPTNPC1SLC6A2SLC6A4SLC6A3
SCHEMBL1742891 0.78 MAOA (0.40) MAPTSLC6A2SLC6A4SLC6A3MAOA
SCHEMBL1956186 0.76 BCL2 (0.49) BCL2L1
SCHEMBL2480796 0.76 BCL2 (0.45)
SCHEMBL1957676 0.74 BCL2 (0.47) MAPT
SCHEMBL8602640 0.69 KMT2A (0.64) MAPTNPC1RAB9ACTNNB1WNT3A
SCHEMBL2535060 0.68 NPC1 (0.51) MAPTNPC1RAB9ACTNNB1WNT3A
SCHEMBL1744461 0.68 HSD11B1 (0.42) MAPTMEN1KMT2AMCL1DRD2
SCHEMBL1742888 0.67 KAT6A (0.48) KAT6ABCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387560-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-11-23 EP claimed
US-8042193-B1 Systems and methods for controlling data access by use of a universal anonymous identifier Albright Associates (US) 2011-10-18 US claimed
WO-2010083441-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-07-22 WO claimed